EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Pharmacological Evaluation of 4 H ‐Chromene‐3‐Carbonitrile Derivatives as Antiplatelet Agents

Afsoon Feizi, Mahvand Oraji, Mona Khoramjouy iD, Mohammadsaeed Kordi, Salimeh Amidi, Marjan Esfahanizadeh, Ali Almasirad, Farzad Kobarfard

Chemical Biology & Drug Design · 2026-06 · 107 (6)

DOI: 10.1111/cbdd.70311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 10.06.2026. Verfasst von Afsoon Feizi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, TeMS.C., Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Benzopyrans, Nitriles. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 4 H ‐Chromene‐3‐carbonitrile derivatives was synthesized, and their in vitro antiplatelet activities were evaluated against arachidonic acid (AA) and adenosine diphosphate (ADP) in plasma. Among the synthesized compounds, 4 H ‐Chromene‐3‐carbonitrile derivative with a 4‐methoxy group ( 4j ) exhibited the most potent antiplatelet activity against AA‐induced aggregation. Almost no activity was observed against the aggregation induced by ADP. Additionally, the in vivo antiplatelet activity of the most potent compound was evaluated using bleeding time and aggregation tests in rats. Compound 4j showed antiplatelet activities in both the oral and intravenous routes of administration in bleeding time and aggregation tests. Notably, the effects were comparable with indomethacin. The structure–activity relationship (SAR) study suggested that the antiplatelet activity of the compound might be governed by the electronic properties of the substituent on the ring of the derivative. The electron‐donating groups at the 4′ position resulted in the most active derivative. Our results show that compound 4j may be an appropriate compound for future investigations in the field of antiplatelet drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsBenzopyransNitrilesAnimalsStructure-Activity RelationshipArachidonic AcidPlatelet AggregationRatsAdenosine DiphosphateMale

Stichwörter der Autor:innen

4H‐Chromeneaggregationantiplatelet activitiesarachidonic acidbleeding timeindomethacinstructure–activity relationship

Substanzen

Platelet Aggregation InhibitorsBenzopyransArachidonic AcidNitrilesAdenosine Diphosphate

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, TeMS.C., Islamic Azad University, Tehran, Iran.
  • Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mona Khoramjouy

Zitieren

APA

Feizi, A., Oraji, M., Khoramjouy, M., Kordi, M., Amidi, S., Esfahanizadeh, M., Almasirad, A., & Kobarfard, F. (2026). Synthesis and Pharmacological Evaluation of 4 H ‐Chromene‐3‐Carbonitrile Derivatives as Antiplatelet Agents. Chemical Biology & Drug Design, 107(6). https://doi.org/10.1111/cbdd.70311

Vancouver

Feizi A, Oraji M, Khoramjouy M, Kordi M, Amidi S, Esfahanizadeh M, et al. Synthesis and Pharmacological Evaluation of 4 H ‐Chromene‐3‐Carbonitrile Derivatives as Antiplatelet Agents. Chemical Biology & Drug Design. 2026;107(6). doi:10.1111/cbdd.70311

BibTeX
@article{Feizi2026,
  author = {Feizi, Afsoon and Oraji, Mahvand and Khoramjouy, Mona and Kordi, Mohammadsaeed and Amidi, Salimeh and Esfahanizadeh, Marjan and Almasirad, Ali and Kobarfard, Farzad},
  title = {Synthesis and Pharmacological Evaluation of 4 H ‐Chromene‐3‐Carbonitrile Derivatives as Antiplatelet Agents},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {6},
  doi = {10.1111/cbdd.70311}
}
Kostenlos starten →